Today: 29 April 2026
Fusemachines stock jumps on IBM-partner deal — FUSE price action to watch before the bell
3 February 2026
1 min read

Fusemachines stock jumps on IBM-partner deal — FUSE price action to watch before the bell

New York, Feb 3, 2026, 07:03 (EST) — Premarket

  • Fusemachines shares slipped 1.5% in premarket trading, coming off a 70.9% surge in the previous session
  • Company revealed a new partnership with ModulAIre, an IBM Platinum Partner
  • A filing revealed Consilium Extended Opportunities Fund LP owns 13.61% of the shares

Shares of Fusemachines Inc dipped 1.5% to $2.66 in premarket Tuesday, following a strong 70.9% jump to $2.70 the day before. The Nasdaq-listed firm, with a market cap near $78 million, traded over 198 million shares on Monday, bouncing between $2.26 and $3.67.

Fuse (ticker: FUSE) announced a strategic alliance with ModulAIre to deliver its AI Studio platform and related services to enterprise clients using IBM systems. The partnership aims at companies ready to move beyond pilot projects to “production-ready” AI deployments, embedding governance frameworks to ensure compliance from the start. CEO Sameer Maskey emphasized the potential for “measurable impact,” while ModulAIre CEO Curren Katz highlighted the demand for tools that “fit naturally” within existing infrastructures. Financial details were not disclosed. globenewswire.com

The significance today lies less in the announcement itself and more in how these AI projects reach the market. Large firms have spent two years experimenting with AI, but expectations have shifted: now it’s about delivering projects that not only launch but also withstand audits and stay live.

Fusemachines aims to sell via partners already embedded in a customer’s tech stack. This approach might speed up sales cycles or have no impact — the market will quickly weigh in, especially for small caps driven by headline news.

A separate regulatory filing revealed Consilium Extended Opportunities Fund LP holds about 4.07 million shares, equal to 13.61% of Fusemachines’ common stock, according to an amended Schedule 13G dated Feb. 2. Jonathan Binder and Charles Cassel are also listed, each showing beneficial ownership around 15.5%, reflecting their control over the fund’s stake plus additional shares reported under their own names.

Fusemachines started trading on Nasdaq under the ticker FUSE in October, the company announced then. It offers enterprise AI products and services, positioning its platform as a tool for clients to deploy and scale AI solutions across various industries.

As regular trading kicks off at 9:30 a.m. EST, eyes will be on whether Monday’s surge sticks when the broader market moves in and spreads narrow. If volume dries up, the stock could slip back just as fast.

Execution remains the key risk. Partnerships often take quarters before generating revenue, and customers managing mission-critical systems typically move at a slow pace—especially once security reviews, data privacy rules, and model oversight come into play.

Next up: the open. Investors want fresh details — early deployments, new customer wins, or additional filings from major holders — that could extend a one-day surge into a sustained move.

Stock Market Today

  • Meta Surpasses Q1 CY2026 Earnings Estimates But Shares Slip
    April 29, 2026, 5:09 PM EDT. Meta Platforms (NASDAQ:META) posted strong Q1 FY2026 results, with revenue rising 33.1% year-on-year to $56.31 billion, beating analyst forecasts by 1.4%. GAAP earnings per share hit $10.44, exceeding estimates by 56.8%. The company forecasted Q2 revenue near $59.5 billion, matching expectations. Despite robust growth, daily active users at 3.56 billion fell short of market estimates, and shares dropped following the report. Meta raised full-year capital expenditure guidance to $135 billion from $125 billion. CEO Mark Zuckerberg highlighted strong momentum and progress in AI with the launch of their first Meta Superintelligence Labs model. Meta's operating margin remained stable at 40.6%, while free cash flow margin slightly declined. The stock trades with a $1.70 trillion market cap amid ongoing growth forecasts, signaling investor caution despite solid fundamentals.

Latest article

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

29 April 2026
Nebius Group N.V. shares rose 5.3% to $142.73 Wednesday as Meta Platforms raised its 2026 capital spending forecast by up to $10 billion, citing higher data center costs. Nebius has a contract to supply Meta with up to $27 billion in AI cloud capacity. Fourth-quarter 2025 revenue jumped 547% to $227.7 million, but the company reported a net loss of $249.6 million.
Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

29 April 2026
Phillips 66 reported an adjusted first-quarter profit of $200 million, or 49 cents per share, beating analyst forecasts of a loss. Strong refining margins and 95% plant utilization offset $839 million in hedge-related losses. Shares rose over 6% after the results. The company also completed its acquisition of Lindsey Oil Refinery assets in the UK.
Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

29 April 2026
Extreme Networks shares surged 28% after reporting fiscal Q3 revenue of $316.9 million, up 11%, and non-GAAP earnings of 26 cents per share, both above estimates. The company forecast Q4 revenue of $330–$335 million, topping FactSet’s $326.9 million estimate. SaaS annual recurring revenue rose 28.6% to $236.4 million. Net income climbed to $10.6 million from $3.5 million a year earlier.
Sandisk stock price: why SNDK is moving again today after a 15% jump
Previous Story

Sandisk stock price: why SNDK is moving again today after a 15% jump

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares
Next Story

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Go toTop